Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes

INTRODUCTION: Randomised controlled trials (RCTs) should have well-defined primary and secondary outcomes to answer questions generated by the main hypotheses. However, for the chronic, inflammatory skin disease hidradenitis suppurativa (HS), the reported outcome measures are numerous and diverse. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorlacius, Linnea, Ingram, John R, Garg, Amit, Villumsen, Bente, Esmann, Solveig, Kirby, Joslyn S, Gottlieb, Alice B, Merola, Joseph F, Dellavalle, Robert, Christensen, Robin, Jemec, Gregor B E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337705/
https://www.ncbi.nlm.nih.gov/pubmed/28219961
http://dx.doi.org/10.1136/bmjopen-2016-014733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337705/
https://www.ncbi.nlm.nih.gov/pubmed/28219961
http://dx.doi.org/10.1136/bmjopen-2016-014733

Ejemplares similares